BC Platforms AG

BC Platforms AG is a Switzerland-based company that excels in real-world data solutions for the life sciences, healthcare, and research sectors, facilitating informed decision-making in drug development and personalized medicine. Founded in 1997 in Zurich, Switzerland, BC Platforms AG specializes in real-world data solutions for the life sciences and healthcare sectors. The company has successfully completed 4 deals to date, with the most recent funding round in November 2022, where it raised CHF 20 million in a GROWTH round led by Jolt Capital. The firm is led by CEO Tero Silvola.

BC Platforms specializes in real-world data solutions and services tailored for the life sciences, healthcare, and research sectors. Their core offerings include a suite of innovative tools designed to manage, analyze, and share health data, thereby facilitating drug development and personalized medicine. BC Platforms leverages over 25 years of experience in genomics and data intelligence to provide clients with actionable insights, enabling better-informed decisions that accelerate drug research and improve patient care outcomes. Their customer base encompasses pharmaceutical companies, healthcare organizations, and research institutions globally, focusing on markets such as North America, Europe, and Asia-Pacific.

The company's solutions address critical challenges in drug research, including data interoperability and secure data sharing, ultimately unlocking valuable insights and fostering collaborations across the healthcare ecosystem. BC Platforms generates revenue through a model based on partnerships and direct service agreements with its clients. These transactions include subscription-based access to their data management and analytics platforms, as well as customized services tailored to specific research needs. Clients typically engage in long-term contracts that provide ongoing access to BC Platforms’ solutions, facilitating continuous collaboration and integration of real-world data into their workflows.

The company's offerings include flagship services such as their Global Data Network and Federated Research capabilities, which are crucial for conducting clinical trials and real-world studies. Specific pricing plans may vary based on the scope of services and the nature of the partnership, ensuring that clients receive tailored solutions to meet their unique data and research requirements. In November 2022, BC Platforms AG raised CHF 20 million in GROWTH funding led by Jolt Capital. The company plans to utilize this funding to expand the scope of its data provision services and enhance its platform with features such as data harmonizing and machine learning tools.

BC Platforms aims to introduce new products that improve data analytics capabilities and is strategically focusing on expanding its market presence in regions including North America, Europe, and Asia-Pacific.